WebDisclosure WebDisclosure
Basculer en Français
10443 Companies
219230 Keywords
148691 Articles
115967 Press releases
Headlines Articles Press releases NexOptic Technology Corp. Remove
  1. Home
  2. Companies
  3. NexOptic Technology Corp.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 12/12/2023 at 19:00, 2 years 5 months ago

    NexOptic Continues to Add Team Strength

    Logo of NexOptic Technology Corp.
  • PRESS RELEASE

    published on 12/04/2023 at 19:11, 2 years 5 months ago

    NexOptic Begins Announcing New Team Additions

    NexOptic announces Louis Suchy as new AI software technical contributor and advisor. Suchy, with 20+ years of experience, to lead AI software development team
    Technology AI Software NexOptic Louis Suchy Team Additions
    Logo of NexOptic Technology Corp.
  • PRESS RELEASE

    published on 11/20/2023 at 15:15, 2 years 6 months ago

    NexOptic Announces Forthcoming Team Additions

    Logo of NexOptic Technology Corp.
Previous page
1 ... 3 4
Accesswire
  • Published on 05/23/2026 at 02:25, 8 minutes ago

    Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet

  • Published on 05/23/2026 at 02:25, 8 minutes ago

    Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec

  • Published on 05/23/2026 at 01:00, 1 hour 33 minutes ago

    LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

  • Published on 05/23/2026 at 00:55, 1 hour 38 minutes ago

    GLG Life Tech Corporation Reports 2026 First Quarter Financial Results

  • Published on 05/23/2026 at 00:15, 2 hours 18 minutes ago

    Molten Metals Completes Airborne Geophysical Survey at Texas Project

View all ACCESSWIRE
EQS Group
  • Published on 05/22/2026 at 22:05, 4 hours 28 minutes ago

    Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH

  • Published on 05/22/2026 at 22:05, 4 hours 28 minutes ago

    Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC

  • Published on 05/22/2026 at 19:51, 6 hours 42 minutes ago

    Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices

  • Published on 05/22/2026 at 18:33, 8 hours ago

    Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring

  • Published on 05/22/2026 at 18:30, 8 hours 3 minutes ago

    Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors

View all EQS
Les Echos
  • Published on 05/22/2026 at 19:35, 6 hours 58 minutes ago

    PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM

  • Published on 05/22/2026 at 18:05, 8 hours 28 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026

  • Published on 05/22/2026 at 18:05, 8 hours 28 minutes ago

    Disclosure of transactions in own shares from May 18 to May 22, 2026

  • Published on 05/22/2026 at 12:52, 13 hours 41 minutes ago

    Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026

  • Published on 05/22/2026 at 12:52, 13 hours 41 minutes ago

    Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy